From:        "Chari, Desi (D)"<EMAIL_ADDRESS>To:        Bill Neuffer/RTP/USEPA/US@EPA
Date:        01/17/2012 03:52 PM
Subject:        Nitric acid NSPS - Information Needed

Dear Bill,

Please find attached information from a single pressure, small scale  Nitric Acid plant operated by the Dow Chemical Company at its Sterlington Louisiana Plant (formerly Angus Chemicals). Hope this information would be helpful as EPA considers our comments on the proposed revisions to the Nitric Acid NSPS regulations.

If you have any questions or comments, please contact me at<PHONE_NUMBER> or<EMAIL_ADDRESS>
Regards,

Desi Chari
Operations Regulatory Services
The Dow Chemical Company
60 Willow Street
North Andover, MA 01845
978-57-1814 (Work)
978-758-6332 (Mobile)


[Federal Register Volume 82, Number 15 (Wednesday, January 25, 2017)]
[Notices]
[Pages 8479-8481]
[FR Doc No: 2017-01607]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-79822; File No. SR-CHX-2017-01]

Self-Regulatory Organizations; Chicago Stock Exchange, Inc.;
Notice of Filing and Immediate Effectiveness of Proposed Rule Change To
Modify the Examination Requirement for CHX Market Maker Authorized
Traders

January 18, 2017.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act'') \1\, and Rule 19b-4 \2\ thereunder, notice is hereby given
that on January 6, 2017 the Chicago Stock Exchange, Inc. (``CHX'' or
the ``Exchange'') filed with the Securities and Exchange Commission
(``Commission'') the proposed rule change as described in Items I and
II below, which Items have been prepared by the Exchange. The
Commission is publishing this notice to solicit comments on the
proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    CHX proposes to amend the Rules of the Exchange (``CHX Rules'') to
modify the examination requirement for CHX Market Maker Authorized
Traders (``MMATs''). The text of this proposed rule change is available
on the Exchange's Web site at (www.chx.com) and in the Commission's
Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the CHX included statements
concerning the purpose of and basis for the proposed rule changes [sic]
and discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The CHX has prepared summaries, set forth in sections A,
B and C below, of the most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Changes

1. Purpose
    The Exchange proposes to amend CHX Rules to modify the examination
requirement for CHX Market Maker Authorized Traders (``MMATs'').
Specifically, the Exchange proposes to eliminate the requirement that
prospective MMATs successfully complete the CHX Market Maker Authorized
Trader Exam, which is an examination currently maintained and
administered by the Exchange for prospective MMATs. In lieu of the CHX
Market Maker Authorized Trader Exam, the Exchange proposes to require
prospective MMATs to successfully complete the Series 57 Securities
Trader Examination \3\ and any other training and/or certification
programs as may be required the Exchange.
---------------------------------------------------------------------------

    \3\ A Representative (as defined under CHX Article 6, Rule 2(b))
that is engaged in securities trading activities, on either an
agency or principal basis, for the Participant (as defined under CHX
Article 1, Rule 1(s)) with which the Representative is associated,
must register with the Exchange as a Securities Trader and pass the
Series 57 Securities Trader Examination. See CHX Article 6, Rule
3(a)(1).
---------------------------------------------------------------------------

    The Exchange notes that the proposed rule change would harmonize
the Exchange's MMAT examination requirement with the MMAT examination
requirements of other national securities exchanges that require
prospective MMATs (or equivalents) to successfully complete the Series
57 Securities Trader Examination.\4\
---------------------------------------------------------------------------

    \4\ See, e.g., NYSE Arca Equities Rule 7.21(b)(2). Other markets
do not explicitly recognize an MMAT registration category but
require any person engaged in the purchase or sale of securities or
other similar instruments for the account of a member organization,
which would include market maker traders, to be registered as a
Securities Trader and pass the Series 57 Securities Trader
Examination. See e.g., paragraph .10 of the Supplementary Material
under NYSE Rule 345; see also, e.g., NASDAQ PHLX Rule 613(f)(2).
---------------------------------------------------------------------------

Background
    Current Article 16, Rule 3(b) provides the registration
requirements for MMATs. Thereunder, current paragraph (b)(2) provides
that to be eligible for registration as an MMAT, a person must be
registered with the Exchange as provided in Article 6 and complete any
other training and/or certification programs as may be required.
Moreover, current paragraph .01(b) of the Interpretations and Policies
of Article 6, Rule 3 provides that prior to the Exchange approving a
Participant's request to register an individual as an MMAT, such
individual must successfully complete the Market Maker Authorized
Trader Exam.
    In order to further streamline and bring consistency to the
qualification and registration requirements for MMATs (or equivalents)
across different markets, the Exchange now proposes to eliminate the
Market Maker Authorized Trader Exam and instead require prospective
MMATs to successfully complete the Series 57 Securities Trader
Examination in order to satisfy the Exchange's MMAT examination
requirement. To this end, the Exchange proposes to delete current
paragraph .01(b) of the Interpretations and Policies of Article 6, Rule
3 in its entirety and amend current Article 16, Rule 3(b)(2) to provide
as follows:

    To be eligible for registration as a MMAT, a person must
successfully complete the Series 57 Securities Trader Examination
and any other training and/or certification programs as may be
required by the Exchange.

The Exchange does not propose to amend or modify any other requirements
related to MMATs or Market Makers in general.

2. Statutory Basis
    The Exchange believes that proposed rule change is consistent with
Section 6(b) of the Act \5\ in general and Section 6(b)(5) of the Act
\6\ in particular, which requires, among other things, that the
Exchange's rules be designed to prevent fraudulent and manipulative
acts and practices, to promote just and equitable principles of trade,
to foster cooperation and coordination with persons engaged in
facilitating transactions in securities, and to remove impediments to
and perfect the mechanism of a free and open market and a national
market system, and, in general, protect investors and the public
interest.
---------------------------------------------------------------------------

    \5\ 15 U.S.C. 78f(b).
    \6\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

    In particular, the Exchange believes that the proposed rule change
will remove impediments to and perfect the mechanism of a free and open
market and a national market system by promoting consistency and
uniformity among different markets \7\ regarding the qualification and
registration requirements for individuals engaged in market making
activities. For those individuals that are engaged in market making
activities across different markets, the proposed rule change will
result in efficiencies with respect to such individuals' registration
and compliance efforts.
---------------------------------------------------------------------------

    \7\ See supra note 4.
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement of Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act. The Exchange believes that
the proposed rule change will reduce the regulatory burden placed on
market participants engaged in market making activities across
different markets. The Exchange believes that the harmonization of the
MMAT examination requirements across the various markets will reduce
burdens on competition by removing impediments to participation in the
national market system.

C. Self-Regulatory Organization's Statement on Comments Regarding the
Proposed Rule Changes Received From Members, Participants or Others

    No written comments were either solicited or received.

III. Date of Effectiveness of the Proposed Rule Changes and Timing for
Commission Action

    The Exchange has filed the proposed rule change pursuant to Section
19(b)(3)(A) of the Act \8\ and Rule 19b-4(f)(6)(iii) thereunder.\9\
Because the foregoing proposed rule change does not: (i) Significantly
affect the protection of investors or the public interest; (ii) impose
any significant burden on competition; and (iii) become operative for
30 days from the date on which it was filed, or such shorter time as
the Commission may designate, it has become effective pursuant to
Section 19(b)(3)(A)(iii) of the Act \10\ and subparagraph (f)(6) of
Rule 19b-4 thereunder.\11\
---------------------------------------------------------------------------

    \8\ 15 U.S.C. 78s(b)(3)(A)(iii).
    \9\ 17 CFR 240.19b-4(f)(6).
    \10\ 15 U.S.C. 78s(b)(3)(A)(iii).
    \11\ In addition, Rule 19b-4(f)(6) requires a self-regulatory
organization to give the Commission written notice of its intent to
file the proposed rule change at least five business days prior to
the date of filing of the proposed rule change, or such shorter time
as designated by the Commission. The Exchange has satisfied this
requirement. 17 CFR 240.19b-4(f)(6).
---------------------------------------------------------------------------

    A proposed rule change filed under Rule 19b-4(f)(6) \12\ normally
does not become operative prior to 30 days after the date of the
filing. However, pursuant to Rule 19b-4(f)(6)(iii),\13\ the Commission
may designate a shorter time if such action is consistent with the
protection of investors and the public interest. In this filing, the
Exchange has asked that the Commission waive the requirement that the
proposed rule change not become operative for 30 days after the date of
the filing so that it may become operative on January 9, 2017.
---------------------------------------------------------------------------

    \12\ Id.
    \13\ Id.
---------------------------------------------------------------------------

    The Exchange notes that the proposal meets the required
qualifications for effectiveness on filing under Section 19(b)(3)(A) of
the Act \14\ and paragraph (f)(6) of Rule 19b-4 thereunder.\15\ As
such, the Exchange has designated this rule filing as non-controversial
under Section 19(b)(3)(A) of the Act \16\ and paragraph (f)(6) of Rule
19b-4 thereunder.\17\ Specifically, the Exchange notes that the waiver
is appropriate as it would be unduly burdensome to prospective MMATs,
especially those who have already passed the Series 57 Securities
Trader Examination, to require them to take the CHX Market Maker
Authorized Trader Exam weeks or days before the proposed rule change is
to become operative. Moreover, based on the same reasons, waiver of the
30-day operative delay is consistent with the protection of investors
and the public interest.
---------------------------------------------------------------------------

    \14\ 15 U.S.C. 78s(b)(3)(A).
    \15\ 17 CFR 240.19b-4.
    \16\ 15 U.S.C. 78s(b)(3)(A).
    \17\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

    The Commission believes that waiving the 30-day operative delay is
consistent with the protection of investors and the public interest
while not imposing any significant burden on competition because it
will make the Chx's qualification and registration requirements for
MMATs consistent with the qualification requirements of the other
markets. Therefore, the Commission hereby waives the 30-day operative
delay and designates the proposed rule change to be operative on
January 9, 2017.\18\
---------------------------------------------------------------------------

    \18\ For purposes only of waiving the 30-day operative delay,
the Commission has also considered the proposed rule's impact on
efficiency, competition, and capital formation. See 15 U.S.C.
78c(f).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act. If the Commission
takes such action, the Commission shall institute proceedings under
Section 19(b)(2)(B) of the Act to determine whether the proposed rule
should be approved or disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views and
arguments concerning the foregoing, including whether the proposal is
consistent with the Act. Comments may be submitted by any of the
following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File No. SR-CHX-2017-01 on the subject line.

Paper Comments

     Send paper comments in triplicate to Robert W. Errett,
Deputy Secretary, Securities and Exchange Commission, 100 F Street NE.,
Washington, DC 20549-1090.

All submissions should refer to File No. SR-CHX-2017-01. This file
number should be included on the subject line if email is used. To help
the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the

Commission, and all written communications relating to the proposed
rule changes between the Commission and any person, other than those
that may be withheld from the public in accordance with the provisions
of 5 U.S.C. 552, will be available for Web site viewing and printing in
the Commission's Public Reference Room, 100 F Street NE., Washington,
DC 20549 on official business days between the hours of 10:00 a.m. and
3:00 p.m. Copies of the filing also will be available for inspection
and copying at the principal office of the CHX. All comments received
will be posted without change; the Commission does not edit personal
identifying information from submissions. You should submit only
information that you wish to make available publicly. All submissions
should refer to File No. SR-CHX-2017-01 and should be submitted on or
before February 15, 2017.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\19\
---------------------------------------------------------------------------

    \19\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Eduardo A. Aleman,
Assistant Secretary.
[FR Doc. 2017-01607 Filed 1-24-17; 8:45 am]
 BILLING CODE 8011-01-P


[Federal Register Volume 76, Number 49 (Monday, March 14, 2011)]
[Notices]
[Page 13655]
[FR Doc No: 2011-5823]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-1957-DR; Docket ID FEMA-2011-0001]

New York; Amendment No. 1 to Notice of a Major Disaster
Declaration

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice amends the notice of a major disaster declaration
for the State of New York (FEMA-1957-DR), dated February 18, 2011, and
related determinations.

DATES: Effective Date: March 7, 2011.

FOR FURTHER INFORMATION CONTACT: Peggy Miller, Office of Response and
Recovery, Federal Emergency Management Agency, 500 C Street, SW.,
Washington, DC 20472,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: The notice of a major disaster declaration
for the State of New York is hereby amended to include the following
areas among those areas determined to have been adversely affected by
the event declared a major disaster by the President in his declaration
of February 18, 2011.

    Bronx and Queens Counties for emergency protective measures
(Category B), including snow assistance, under the Public Assistance
program for any continuous 48-hour period during or proximate to the
incident period.

The following Catalog of Federal Domestic Assistance Numbers (CFDA)
are to be used for reporting and drawing funds: 97.030, Community
Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis Counseling;
97.033, Disaster Legal Services; 97.034, Disaster Unemployment
Assistance (DUA); 97.046, Fire Management Assistance Grant; 97.048,
Disaster Housing Assistance to Individuals and Households In
Presidentially Declared Disaster Areas; 97.049, Presidentially
Declared Disaster Assistance--Disaster Housing Operations for
Individuals and Households; 97.050 Presidentially Declared Disaster
Assistance to Individuals and Households--Other Needs; 97.036,
Disaster Grants--Public Assistance (Presidentially Declared
Disasters); 97.039, Hazard Mitigation Grant.

W. Craig Fugate,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2011-5823 Filed 3-11-11; 8:45 am]
BILLING CODE 9111-23-P


[Federal Register Volume 88, Number 172 (Thursday, September 7, 2023)]
[Notices]
[Pages 61655-61656]
[FR Doc No: 2023-19246]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[SEC File No. 270-317, OMB Control No. 3235-0360]

Proposed Collection; Comment Request; Extension: Form N-17F-2

Upon Written Request, Copies Available From: Securities and Exchange
Commission, Office of FOIA Services, 100 F Street NE, Washington, DC
20549-2736.

    Notice is hereby given that, pursuant to the Paperwork Reduction
Act of 1995 (44 U.S.C. 350l et seq.), the Securities and Exchange
Commission (the ``Commission'') is soliciting comments on the
collection of information summarized below. The Commission plans to
submit this existing collection of information to the Office of
Management and Budget for extension and approval.
    Form N-17f-2 (17 CFR 274.220) under the Investment Company Act is
entitled ``Certificate of Accounting of

Securities and Similar Investments in the Custody of Management
Investment Companies.'' Form N-17f-2 is the cover sheet for the
accountant examination certificates filed under rule 17f-2 (17 CFR
270.17f-2) by registered management investment companies (``funds'')
maintaining custody of securities or other investments. Form N-17f-2
facilitates the filing of the accountant's examination certificates
prepared under rule 17f-2. The use of the form allows the certificates
to be filed electronically, and increases the accessibility of the
examination certificates to both the Commission's examination staff and
interested investors by ensuring that the certificates are filed under
the proper Commission file number and the correct name of a fund.
    Commission staff estimates that it takes: (i) on average 1.25 hours
of fund accounting personnel at a total cost of $315 to prepare each
Form N-17f-2; \1\ and (ii) .75 hours of administrative assistant time
at a total cost of $70.50 to file the Form N-17f-2 with the
Commission.\2\ Approximately 165 funds currently file Form N-17f-2 with
the Commission. Commission staff estimates that on average each fund
files Form N-17f-2 three times annually for a total annual hourly
burden per fund of approximately 6 hours at a total cost of $1,156.50.
The total annual hour burden for Form N-17f-2 is therefore estimated to
be approximately 990 hours at a total cost of approximately
$190,822.50.\3\ Form N-17f-2 does not impose any paperwork related cost
burdens other than this internal hour cost.
---------------------------------------------------------------------------

    \1\ This estimate is based on the following calculation: 1.25 x
$252 (fund senior accountant's hourly rate) = $315.
    \2\ This estimate is based on the following calculation: .75 x
$94 (administrative assistant hourly rate) $70.50.
    \3\ This estimate is based on the following calculation: 165
funds x $1,156.50 (total annual cost per fund) = $190,822.50.
---------------------------------------------------------------------------

    The estimate of average burden hours is made solely for the
purposes of the Paperwork Reduction Act, and is not derived from a
comprehensive or even a representative survey or study of the costs of
Commission rules and forms. Complying with the collections of
information required by Form N-17f-2 is mandatory for those funds that
maintain custody of their own assets. Responses will not be kept
confidential. An agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information unless it displays
a currently valid control number.
    Written comments are invited on: (a) whether the proposed
collection of information is necessary for the proper performance of
the functions of the Commission, including whether the information
shall have practical utility; (b) the accuracy of the Commission's
estimate of the
    burden of the collection of information; (c) ways to enhance the
quality, utility, and clarity of the information collected; and (d)
ways to minimize the burden of the collection of information on
respondents, including through the use of automated collection
techniques or other forms of information technology. Consideration will
be given to comments and suggestions submitted by November 6, 2023.
    An agency may not conduct or sponsor, and a person is not required
to respond to, a collection of information under the PRA unless it
displays a currently valid OMB control number.
    Please direct your written comments to: David Bottom, Acting
Director/Chief Information Officer, Securities and Exchange Commission,
c/o John Pezzullo, 100 F Street NE, Washington, DC 20549 or send an
email to: [email protected] .

    Dated: August 31, 2023.
Sherry R. Haywood,
Assistant Secretary.
[FR Doc. 2023-19246 Filed 9-6-23; 8:45 am]
BILLING CODE 8011-01-P


EPA REGISTRATION DIVISION COMPANY NOTICE OF FILING FOR PESTICIDE PETITIONS PUBLISHED IN THE FEDERAL REGISTER

EPA Registration Division contact: PV Shah, Registration Division (7505P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-001; telephone number:<PHONE_NUMBER>; email address<EMAIL_ADDRESS>

INSTRUCTIONS:  Please utilize this outline in preparing the pesticide petition.  In cases where the outline element does not apply, please insert "NA-Remove" and maintain the outline. Please do not change the margins, font, or format in your pesticide petition. Simply replace the instructions that appear in green, i.e., "[insert company name]," with the information specific to your action.

TEMPLATE:

BASF Corporation

[EPA Petition number: IN-11044]

	EPA has received a pesticide petition (IN-11044) from BASF Corporation, 100 Park Avenue, Florham Park, NJ  07932 proposing, pursuant to section 408(d) of the Federal Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 346a(d), to amend 40 CFR part 180 to establish an exemption from the requirement of a tolerance for  Amine salt of styrene acrylic polymer, ammonium salt under 40 CFR 180.960 when used as an inert ingredient as a dispersant/binder in a pesticide formulation without limitation.  EPA has determined that the petition contains data or information regarding the elements set forth in section 408 (d)(2) of  FDDCA; however, EPA has not fully evaluated the sufficiency of the submitted data at this time or whether the data supports granting of the petition. Additional data may be needed before EPA rules on the petition.

A. Residue Chemistry

	1. Plant metabolism. "NA-Remove"

	2. Analytical method. "NA-Remove"

	3. Magnitude of residues. "NA-Remove"

B. Toxicological Profile

	The definition of a polymer is given in 40 CFR 723.250(b). The following exclusion criteria for identifying these low risk polymers are described in 40 CFR 723.250(d).

       Amine salt of styrene acrylic polymer, ammonium salt is a polymer as defined by 40 CFR 723.250(b).   In addition, Amine salt of styrene acrylic polymer, ammonium salt contains at least 3 monomer units which are covalently bound to at least one other monomer unit or other reactant and consists of a simple weight majority of the polymer molecules.   The monomer sequences form uninterrupted strings in the polymer and distribution of the molecular weight of the polymer is due largely to the number of monomer units in the individual molecules.              2.       Amine salt of styrene acrylic polymer, ammonium salt consists of a number average molecular weight greater than 1,000 daltons and less than 10,000 daltons, <10% of its oligomeric material weighing below 500 daltons and <25% of its oligomeric material weighing less than 1,000 daltons.

             3.  Amine salt of styrene acrylic polymer, ammonium salt, is not a cationic polymer nor is it reasonably anticipated to become a cationic polymer in a natural aquatic environment.  The polymer does not contain any functional groups which would dissociate into a cationic moiety in water.  The polymer does not contain a net positively charged atom(s) or associated groups of atoms covalently linked to its polymer molecule.

      4.  The polymer contains as an integral part of its composition the atomic elements carbon, hydrogen, nitrogen and oxygen.

      5.  The polymer does not contain as an integral part of its composition, except as impurities, any element other than those listed in 40 CFR 723.250(d)(2)(ii).

      6.  The polymer is neither designed nor can it be reasonably anticipated to substantially degrade, decompose, or depolymerize.  For the purposes of this section, degradation, decomposition, or depolymerization mean those types of chemical change that convert a polymeric substance into simpler, smaller substances, through processes including but not limited to oxidation, hydrolysis, attack by solvents, heat, light, or microbial action.              7.  The polymer is manufactured or imported from monomers and/or reactants that are already included on the TSCA Chemical Substance Inventory or manufactured under an applicable TSCA section 5 exemption.

      8.  The polymer is not a water absorbing polymer with a number average molecular weight (MW) greater than or equal to 10,000 daltons.  Additionally, the polymer, Amine salt of styrene acrylic polymer, ammonium salt, also meets as required the following exemption criteria specified in 40 CFR 723.250(e).  The polymer is not designed to be a water-absorbing polymer that is capable of absorbing its weight of water.              9. The polymer does not contain, as an integral part of its composition, except as impurities, one or more of the following perfluoroalkyl moieties consisting of a CF3- or longer chain length:       	a. Perfluoroalkyl sulfonates (PFAS),       	b. Perfluoroalkyl carboxylates (PFAC),       	c. Fluorotelomers,       	d. Perfluoroalkyl moieties that are covalently bound to either a   carbon or sulfur atom where the carbon or sulfur atom is an integral part of the polymer molecule.

    Thus, Amine salt of styrene acrylic polymer, ammonium salt meets all the criteria for a polymer to be considered low risk under 40 CFR 723.250. Based on its conformance to the above criteria, no mammalian toxicity is anticipated from dietary, inhalation, or dermal exposure to Amine salt of styrene acrylic polymer, ammonium salt.

C. Aggregate Exposure

	For the purposes of assessing potential exposure under this exemption, Amine salt of styrene acrylic polymer, ammonium salt could be present in all raw and processed agricultural commodities and drinking water, and that non-occupational non-dietary exposure was possible. The number average MW of Amine salt of styrene acrylic polymer, ammonium salt is greater than 1,000 daltons and less than 10,000 daltons. Generally, a polymer of this size would be poorly absorbed through the intact gastrointestinal tract or through intact human skin. Since Amine salt of styrene acrylic polymer, ammonium salt conforms to the criteria that identify a low risk polymer, there are no concerns for risks associated with any potential exposure scenarios that are reasonably foreseeable. Therefore a tolerance is not necessary to protect the public health.

D. Cumulative Effects       Section 408 (b)(2)(D)(v) of FFDCA requires that, when considering whether to establish, modify, or revoke a tolerance or tolerance exemption, ``available information'' concerning the cumulative effects of a particular chemical's residues and ``other substances that have a common mechanism of toxicity'', must be considered. At this time, available data to determine whether Amine salt of styrene acrylic polymer, ammonium salt has a common mechanism of toxicity with other substances is not available.

Since Amine salt of styrene acrylic polymer, ammonium salt meets the definition of a low concern polymer, Amine salt of styrene acrylic polymer, ammonium salt is not expected to show any cumulative effects.

E. Safety Determination

      	1. U.S. population. Based on the conformance to the criteria used to identify a low risk polymer, there is a reasonable certainty of no harm to the U.S. population, including infants and children, from aggregate exposure to residues of Amine salt of styrene acrylic polymer, ammonium salt.

      	2. Infants and children. Section 408 of the FFDCA provides that EPA shall apply an additional tenfold margin of safety for infants and children in the case of threshold effects to account for prenatal and postnatal toxicity and the completeness of the data base unless EPA concludes that a different margin of safety will be safe for infants and children. Due to the expected low toxicity of Amine salt of styrene acrylic polymer, ammonium salt, based on the polymer meeting the definition of a low risk polymer under 40 CFR 723.250 a safety factor analysis to assess the risk is not necessary. For the same reasons the additional tenfold safety factor is unnecessary.

F. International Tolerances

	There are no CODEX maximum residue limits established for Amine salt of styrene acrylic polymer, ammonium salt in or on crops or commodities at this time.

G. Other Considerations

      1. Endocrine Disruptors:  There is no available evidence that Amine salt of styrene acrylic polymer, ammonium salt is an endocrine disruptor.